SPI
16.823,86
PKT
+11,23
PKT
+0,07
%
Werbung
Analysen zu SPI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
16.12.11 | Swiss Re overweight | J.P. Morgan Cazenove | |
16.12.11 | Roche outperform | Credit Suisse Group | |
16.12.11 | Holcim neutral | UBS AG | |
16.12.11 | u-blox hold | Vontobel Research | |
15.12.11 | UBS neutral | WestLB AG | |
15.12.11 | Swatch (I) neutral | J.P. Morgan Cazenove | |
15.12.11 | Roche buy | Deutsche Bank AG | |
15.12.11 | Swisscom buy | Société Générale Group S.A. (SG) | |
15.12.11 | u-blox hold | Vontobel Research | |
15.12.11 | Swiss Life buy | Vontobel Research | |
15.12.11 | Swisscom hold | Vontobel Research | |
15.12.11 | Novartis hold | Vontobel Research | |
14.12.11 | Roche overweight | J.P. Morgan Cazenove | |
14.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
14.12.11 | Swisscom hold | Vontobel Research | |
14.12.11 | Sika buy | Vontobel Research | |
14.12.11 | Rieter hold | Vontobel Research | |
13.12.11 | Holcim hold | Deutsche Bank AG | |
13.12.11 | Holcim buy | Deutsche Bank AG | |
13.12.11 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
13.12.11 | Swiss Re underperform | Banc of America Securities-Merrill Lynch | |
13.12.11 | Holcim neutral | UBS AG | |
13.12.11 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
13.12.11 | Novartis buy | WestLB AG | |
13.12.11 | Givaudan underperform | Cheuvreux SA | |
13.12.11 | Roche outperform | Credit Suisse Group | |
13.12.11 | Holcim hold | Vontobel Research | |
13.12.11 | Orell Fuessli hold | Vontobel Research | |
13.12.11 | Cicor Technologies buy | Vontobel Research | |
13.12.11 | Novartis hold | Vontobel Research | |
13.12.11 | Novartis outperform | Credit Suisse Group | |
12.12.11 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
12.12.11 | Swiss Re buy | Vontobel Research | |
12.12.11 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
09.12.11 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
09.12.11 | Nestlé halten | Independent Research GmbH | |
08.12.11 | Roche overweight | J.P. Morgan Cazenove | |
08.12.11 | ABB (Asea Brown Boveri) outperform | Credit Suisse Group | |
08.12.11 | Roche overweight | Barclays Capital | |
08.12.11 | Roche buy | Citigroup Corp. |